Asahi shares mark weekly slide after cyberattack halts production
LONDON - Convatec Group Plc (LSE:CTEC) announced Thursday it has priced an offering of $500 million in senior notes with a 5.300% interest rate maturing in 2035, to be issued by its subsidiary 180 Medical, Inc.
The notes will be issued at 99.617% of their nominal value, with settlement expected on October 8, 2025, subject to customary closing conditions.
The medical products and technologies company, which specializes in solutions for chronic conditions, intends to use the proceeds to refinance existing debt. This includes prepaying its outstanding term loan facility in full, prepaying a portion of its revolving credit facility, and for general corporate purposes.
Convatec, a constituent of the FTSE 100 Index, reported revenues exceeding $2 billion in 2024. The company operates in approximately 90 countries with more than 10,000 employees and maintains leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care.
The notes offering is being made through an offering memorandum and is not registered under the U.S. Securities Act. In the United States, the notes are being offered only to qualified institutional buyers under Rule 144A, and to non-U.S. persons in offshore transactions under Regulation S.
The information is based on a press release statement from Convatec Group Plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.